Phase I/II trial of fludarabine in combination with intravenous busulfan and allogeneic progenitor cell support for patients with high risk hematologic malignancies; Dose matters in reduced intensity regimens Meeting Abstract
| Authors: | Parmar, S.; Rondon, G.; Thall, P. F.; Bassett, R.; de Lima, M.; Hosing, C. M.; Anderlini, P.; Kebriaei, P.; Khouri, I.; Ganesan, P.; Efebera, Y. A.; Champlin, R.; Giralt, S. A. |
| Abstract Title: | Phase I/II trial of fludarabine in combination with intravenous busulfan and allogeneic progenitor cell support for patients with high risk hematologic malignancies; Dose matters in reduced intensity regimens |
| Meeting Title: | 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis |
| Journal Title: | Blood |
| Volume: | 118 |
| Issue: | 21 |
| Meeting Dates: | 2011 Dec 10-13 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2011-11-01 |
| Start Page: | 848 |
| Language: | English |
| ACCESSION: | WOS:000299597102539 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V118.21.1944.1944 |
| Notes: | --- - Meeting Abstract: 1944 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos" |
